Currently out of the existing stock ratings of Jay Olson, 315 are a BUY (94.31%), 18 are a HOLD (5.39%), 1 are a SELL (0.3%).

Jay Olson

Work Performance Price Targets & Ratings Chart

Analyst Jay Olson, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 44.89% that have a potential upside of 31.38% achieved within 157 days.

Jay Olson’s has documented 732 price targets and ratings displayed on 51 stocks. The coverage is on Healthcare, Industrials, Financial Services sectors.

Most recent stock forecast was given on BCYC, Bicycle Therapeutics Ltd at 10-Aug-2025.

Wall Street Analyst Jay Olson

Analyst best performing recommendations are on CINC (CINCOR PHARMA).
The best stock recommendation documented was for PRTA (PROTHENA PLC) at 6/1/2021. The price target of $45 was fulfilled within 10 days with a profit of $17.56 (63.99%) receiving and performance score of 63.99.

Average potential price target upside

of $221 (59.58%) on BIVI (BIOVIE).
of $72.72 (49.2%) on MDGL (MADRIGAL PHARMACEUTICALS).
of $59.11 (28.07%) on AMGN (AMGEN).

ACAD ACADIA Pharmaceuticals AMGN Amgen BCYC Bicycle Therapeutics Ltd BIIB Biogen CBAY Cymabay Therapeu CRSP Crispr Therapeutics AG EDIT Editas Medicine FREQ Frequency Therapeutics ICPT Intercept Pharmaceuticals MRTX Mirati Ther NBIX Neurocrine Biosciences NTLA Intellia Therapeutics PRTA Prothena plc PTLA Portola Pharmaceuticals SAGE Sage Therapeutic SGEN Seagen SRRA Sierra Oncology TXMD TherapeuticsMD ENTA Enanta Pharmaceuticals AXON Axon Enterprise AYLA Ayala Pharmaceuticals DNLI Denali Therapeutics ETN Eaton PLC EXEL Exelixis FOCS Focus Financial Partners INCY yte JSPR Jasper Therapeutics KRTX Karuna Therapeutics MDGL Madrigal Pharmaceuticals NKTR Nektar Therapeutics BIVI Biovie CINC CinCor Pharma ETNB 89bio CGTX Cognition Therapeutics MDCO The Medicines Company RLMD Relmada Therapeutics RVMD Revolution Medicines VKTX Viking Therapeutics VYGR Voyager Therapeutics MRNS Marinus Pharmaceuticals GLTO Galecto INO Inovio Pharmaceuticals IONS Ionis Pharmaceuticals STRO Sutro Biopharma TERN Terns Pharmaceuticals QTTB Q32 Bio CNAT Conatus Pharmaceuticals INDP Indaptus Therapeutics MDWD Mediwound Ltd MNKD MannKind Corp NTEC Intec Pharma Ltd

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Tessa Romero (JPMORGAN)